Co-Authors
This is a "connection" page, showing publications co-authored by HUGO VILLANUEVA and MICHAEL ITTMANN.
Connection Strength
0.372
-
Characterizing treatment resistance in muscle invasive bladder cancer using the chicken egg chorioallantoic membrane patient-derived xenograft model. Heliyon. 2022 Dec; 8(12):e12570.
Score: 0.194
-
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy. Cancer Treat Rev. 2026 Jul 16; 149:103190.
Score: 0.062
-
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy. medRxiv. 2025 Aug 12.
Score: 0.058
-
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer. Cell Rep Med. 2025 Aug 19; 6(8):102255.
Score: 0.058